Controlled Drugs and Substances Act
Schedule I
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
11.
Benzazocines, their salts, derivatives and salts of derivatives including:
(1)
Phenazocine (1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-ol)
UK: MDA Part I Class A Section 1(a) Phenazocine
UN: Narcotics Part 1 Section 1 Phenazocine
US: CSA Schedule II Section c Subsection 22 Phenazocine
PubChem: 14707; ChemSpider: 391631; Drugs Forum: Phenazocine; Wikipedia: Phenazocine
(2)
Metazocine (1,2,3,4,5,6-Hexahydro-3,6,11-trimethyl-2,6-methano-3-benzazocin-8-ol)
UK: MDA Part I Class A Section 1(a) Metazocine and Part II Class B Section 1(a) Metazocine
UN: Narcotics Part 1 Section 1 Metazocine and Psychotropics Schedule III Metazocine
US: CSA Schedule II Section c Subsection 14 Metazocine
PubChem: 3037886; ChemSpider: 391630; Wikipedia: Metazocine
(3)
Pentazocine (1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol)
US: CSA Schedule IV Section g Subsection 1 Pentazocine
PubChem: 4736; ChemSpider: 390041; Bluelight: Pentazocine; Drugs Forum: Pentazocine; Wikipedia: Pentazocine
but not including
(4)
Cyclazocine (1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(cyclopropylmethyl)-2,6-methano-3-benzazocin-8-ol)
11 March 2016 · Creative Commons BY-NC-SA ·